First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.
Also called NCT02236975
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 168 participants
- Registry
-
NCT02236975
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Netherlands, Portugal, Spain
- Registry status
- Completed
Technical summary
Registry record NCT02236975. Randomized; single masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2016-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- BuMA Supreme Biodegradable drug coating coronary stent system
- Intervention (Device)
- Resolute Integrity durable polymer stent system
- Lead sponsor
- Sino Medical Sciences Technology Inc.
Record details
- Record id
cardio:ct-nct02236975- Content hash
7f037c9c04d2c66477c7a3a0877aedfc3ee47ac2bf082c8a7ed8946710f85bc4